Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

2.88
Delayed Data
As of Jan 19
 -0.04 / -1.37%
Today’s Change
1.24
Today|||52-Week Range
3.65
-6.49%
Year-to-Date
More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017
Jan 11 / MotleyFool.com - Paid Partner Content
1 Reason Amarin's Stock Skyrocketed in 2016
Jan 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close2.92
Today’s open2.91
Day’s range2.88 - 2.94
Volume1,251,771
Average volume (3 months)2,467,407
Market cap$788.3M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+35.38%
Earnings growth (next 5 years)-249.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...-0.21-1.17%
RGNXRegenxbio Inc+0.20+1.01%
BSTCBiospecifics Technol...-1.21-2.31%
CDXSCodexis Inc+0.05+1.04%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs